Category Press Releases

Uniphar

Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone

Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone In a significant advancement that underscores its continued investment in next-generation healthcare solutions, Uniphar, a global leader in pharmaceutical and medtech services, has officially launched its 10th cell and…

Read MoreUniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone
QIAGEN

QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025

QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025 QIAGEN N.V. Frankfurt Prime Standard: QIA), a global leader in molecular diagnostics and sample-to-insight technologies, today announced a comprehensive lineup of product innovations and…

Read MoreQIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025
Cytokinetics

Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes meaningful equity incentives. On April 15, 2025, the company announced…

Read MoreCytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4)
Bruker

Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes

Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P, a next-generation miniature two-photon (2P) fluorescence microscope that brings deep-tissue,…

Read MoreBruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes
Tivic Health

Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment

Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment Tivic Health Systems, Inc. , a diversified therapeutics company focused on advancing innovative treatment solutions, has made a significant move in expanding its therapeutic pipeline. On March…

Read MoreTivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment
Scipher Medicine

Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment

Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment In a groundbreaking move aimed at advancing precision medicine in the realm of autoimmune diseases, Scipher Medicine, a leading innovator in precision medicine for autoimmune conditions, has entered…

Read MoreScipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment
Nuclera

Nuclera Enhances eProtein Platform to Support Membrane Protein Production

Nuclera Enhances eProtein Platform to Support Membrane Protein Production Nuclera, a leading biotechnology innovator specializing in rapid protein expression and optimization, today announced a significant enhancement to its flagship benchtop platform, the eProtein Discovery™ system. The company has unveiled a…

Read MoreNuclera Enhances eProtein Platform to Support Membrane Protein Production
ATED

ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease

ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease In a significant stride toward revolutionizing the diagnosis and monitoring of Parkinson’s disease (PD), UK-based biotech company ATED Therapeutics Ltd. has announced the development of a novel, non-invasive…

Read MoreATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease